1. Simultaneous quantitative analysis of phosphocreatine, creatine and creatinine in plasma of children by HPLC-MS/MS method: Application to a pharmacokinetic study in children with viral myocarditis.
- Author
-
Sun N, Li Q, Zhao L, He H, Zhang M, and Wang X
- Subjects
- Adolescent, Child, Chromatography, High Pressure Liquid methods, Creatine chemistry, Creatine pharmacokinetics, Creatinine chemistry, Creatinine pharmacokinetics, Drug Stability, Female, Humans, Limit of Detection, Linear Models, Male, Phosphocreatine chemistry, Phosphocreatine pharmacokinetics, Reproducibility of Results, Tandem Mass Spectrometry methods, Creatine blood, Creatinine blood, Myocarditis blood, Phosphocreatine blood, Virus Diseases blood
- Abstract
A simple and rapid HPLC-MS/MS method was developed and validated for simultaneous measurement of phosphocreatine and its metabolites creatine and creatinine in children's plasma. A 50 μL aliquot of plasma was prepared by protein precipitation with acetonitrile-water (1000 μL, 1:1, v/v) followed by separation on a Hypersil Gold C
18 column (35°C) with gradient mobile phase consisting of 2 mm ammonium acetate aqueous solution (pH 10) and methanol at a flow rate of 0.3 mL/min and analyzed by mass spectrometry in both positive (phosphocreatine) and negative (creatine and creatinine) ion multiple reaction monitoring mode. Good linearity (r > 0.99) was obtained for the three analytes. The intra-day and inter-day values of CV were <5.46% (-13.09% ≤ RE ≤ 2.57%). The average recoveries of the three analytes were 70.9-97.5%. No obvious impact was found for the quantitation of three analytes in normal, hemolyzed and hyperlipemic plasma. In the end, this method was successfully applied to a pharmacokinetic study of phosphocreatine in children (six cases) with viral myocarditis of children after intravenous infusion of 2 g of the test drug. The pharmacokinetc parameters of phosphocreatine/creatine were as follows: t1/2 0.24/0.83 h, Tmax 0.49/0.55 h, Cmax 47.34/59.29 μg/mL, AUClast 17.07/59.63 h μg/mL, AUCinf 17.16/79.01 h μg/mL and MRT 0.29/0.67 h., (© 2019 John Wiley & Sons, Ltd.)- Published
- 2019
- Full Text
- View/download PDF